Thomas Fox, MBChB, MD, PhD, dives into the complexities of treating primary immunodeficiencies with bone marrow transplants, highlighting the necessity for highly individualized patient assessments. He introduces two…
Visit the fictional town of Deficiency, Maine, where primary immunodeficiencies affecting both B and T cells are explored through a captivating narrative. The scene is set during summer…
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Nicotinamide riboside appears to be the best precursor supplement available to help maintain or increase NAD+ levels. All cells and tissues can use it, and at high doses…
